Updated Retinal Bulletin

Advances in retinal research and cures.

Chronic Central Serous Chorioretinopathy Treatment Results

Half-dose photodynamic therapy is superior to high-density subthreshold micropulse laser treatment in chronic central serous chorioretinopathy, regardless of the presence of focal or diffuse leakage on fluorescein

“Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.

Am. J. Ophthalmol 205:1-10, September 2019
Thomas J. Van Rijssen, Elon H.C. Van Dijk, Paula Scholz, Myrte B. Breukink, Rocio Blanco-Garavito, Eric H. Souied, Jan E.E. Keunen, Robet E. MaClaren, Giuseppe Querques, Sascha Fauser, Susan M. Downes, Carel B. Hoyng, and Camiel J.F. Boon

Icon - PDFFull Paper: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.
Download (113K PDF)